Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 27, 2023

BUY
$3.0 - $4.97 $1,725 - $2,857
575 Added 2.72%
21,719 $72,000
Q4 2022

Feb 07, 2023

BUY
$4.35 - $6.17 $3,397 - $4,818
781 Added 3.84%
21,144 $101,000
Q3 2022

Nov 07, 2022

BUY
$5.49 - $8.79 $516 - $826
94 Added 0.46%
20,363 $116,000
Q2 2022

Jul 28, 2022

BUY
$5.33 - $8.18 $108,033 - $165,800
20,269 New
20,269 $144,000

Others Institutions Holding AVIR

About Atea Pharmaceuticals, Inc.


  • Ticker AVIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,258,600
  • Market Cap $255M
  • Description
  • Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...
More about AVIR
Track This Portfolio

Track Arizona State Retirement System Portfolio

Follow Arizona State Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Arizona State Retirement System with notifications on news.